Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 30, 2022	Jan. 31, 2021	Jan. 26, 2020
Cash flows from operating activities:
Net income	$ 125,645	$ 59,867	$ 31,866
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	30,892	31,867	39,951
Amortization of right-of-use assets	4,410	3,991	4,015
Investment impairments and credit loss reserves	1,337	6,769	1,211
Accretion of deferred financing costs and debt discount	481	482	484
Write-off of deferred financing cost and debt discount	0	0	514
Deferred income taxes	(3,782)	(7,396)	(5,596)
Share-based compensation	51,189	52,986	52,049
Loss (gain) on disposition of business operations and assets	(54)	61	378
Changes in the fair value of contingent earn-out obligations	(13)	(33)	(2,345)
Equity in net (gains) losses of equity method investments	(2,115)	(329)	(109)
Corporate owned life insurance, net	4,766	6,508	5,613
Changes in assets and liabilities:
Accounts receivable, net	(1,074)	(8,506)	17,296
Inventories	(26,509)	(14,484)	(9,331)
Other assets	11,176	(15,069)	2,415
Accounts payable	(2,145)	3,565	2,603
Accrued liabilities	17,829	2,309	(20,563)
Income taxes payable	0	0	(2,105)
Other liabilities	(8,910)	(3,658)	270
Net cash provided by operating activities	203,123	118,930	118,616
Cash flows from investing activities:
Proceeds from sales of property, plant and equipment	110	385	352
Purchases of property, plant and equipment	(26,181)	(32,734)	(23,056)
Purchases of investments	(8,245)	(10,938)	(11,630)
Proceeds from sale of investments	0	378	0
Premiums paid for corporate-owned life insurance	(6,000)	0	0
Net cash used in investing activities	(40,316)	(42,909)	(34,334)
Cash flows from financing activities:
Payments of term loans	0	0	(115,312)
Proceeds from revolving line of credit	20,000	0	201,000
Payments of revolving line of credit	(28,000)	(16,000)	(101,000)
Deferred financing costs	0	(30)	(2,056)
Payments of earn-out	(215)	0	(237)
Payment for employee share-based compensation payroll taxes	(19,413)	(21,490)	(21,507)
Proceeds from exercise of stock options	5,277	8,499	6,002
Repurchase of common stock	(129,746)	(71,433)	(70,219)
Contributions from Noncontrolling Interest	0	0	251
Net cash used in financing activities	(152,097)	(100,454)	(103,078)
Net increase (decrease) in cash and cash equivalents	10,710	(24,433)	(18,796)
Cash and cash equivalents at beginning of period	268,891	293,324	312,120
Cash and cash equivalents at end of period	279,601	268,891	293,324
Supplemental disclosure of cash flow information
Interest paid	4,295	4,880	7,906
Income taxes paid	3,333	8,406	11,157
Non-cash items
Capital expenditures in accounts payable	5,513	2,862	4,247
Conversion of note into equity	$ 626	$ 0	$ 0